quantisnow
FeedTopReportsPricing
⌘K
Live feed
02:48:47·735d
NEWSRelease
Biophytis SA logo

Biophytis Announces ADR Ratio Change: From 100 To 4,000 Shares Per ADS, Effective April 23

BPTS· Biophytis SA
Health Care
Original source

Companies

  • BPTS
    Biophytis SA
    Health Care

Recent analyst ratings

  • Oct 25UpdateHC Wainwright & Co.$15.00

Related

  • PR570d
    Biophytis Publishes First-Half Financial Results and Provides an Update on its Business Activities
  • PR641d
    Biophytis Deploys its Partnership Strategy and Signs Two Contracts with Local Agents in Asia
  • PR652d
    Biophytis Obtains IND Approval from the FDA to Start its Phase 2 OBA Study in Obesity
  • PR662d
    Biophytis Presented its Phase 2-3 COVA Study Results in Severe Forms of Covid-19 at the WCID in Paris
  • PR673d
    Biophytis grants Blanver Exclusive Rights to BIO101 in Latin America in Deal Valued at up to €108 Million
  • PR673d
    Biophytis Extends Its Contract With Atlas to Secure Financing for Its Business Activities
  • PR681d
    Biophytis Announces the Successful Industrial Transfer of BIO101 (20-hydroxyecdysone) Production by its Service Provider Seqens
  • PR683d
    Biophytis Announces Filing of an IND Application with the US FDA for its Phase 2 Study in Obesity
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022